Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16+ Cell Subsets.

Stobutzki N, Schlickeiser S, Streitz M, Stanko K, Truong KL, Akyuez L, Vogt K, Appelt C, Pascher A, Blau O, Gerlach UA, Sawitzki B.

Front Immunol. 2019 May 7;10:866. doi: 10.3389/fimmu.2019.00866. eCollection 2019.

2.

Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.

Christen F, Hoyer K, Yoshida K, Hou HA, Waldhueter N, Heuser M, Hills RK, Chan W, Hablesreiter R, Blau O, Ochi Y, Klement P, Chou WC, Blau IW, Tang JL, Zemojtel T, Shiraishi Y, Shiozawa Y, Thol F, Ganser A, Löwenberg B, Linch DC, Bullinger L, Valk PJM, Tien HF, Gale RE, Ogawa S, Damm F.

Blood. 2019 Mar 7;133(10):1140-1151. doi: 10.1182/blood-2018-05-852822. Epub 2019 Jan 4.

PMID:
30610028
3.

Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.

Frick M, Chan W, Arends CM, Hablesreiter R, Halik A, Heuser M, Michonneau D, Blau O, Hoyer K, Christen F, Galan-Sousa J, Noerenberg D, Wais V, Stadler M, Yoshida K, Schetelig J, Schuler E, Thol F, Clappier E, Christopeit M, Ayuk F, Bornhäuser M, Blau IW, Ogawa S, Zemojtel T, Gerbitz A, Wagner EM, Spriewald BM, Schrezenmeier H, Kuchenbauer F, Kobbe G, Wiesneth M, Koldehoff M, Socié G, Kroeger N, Bullinger L, Thiede C, Damm F.

J Clin Oncol. 2019 Feb 10;37(5):375-385. doi: 10.1200/JCO.2018.79.2184. Epub 2018 Nov 7.

PMID:
30403573
4.

Single Nucleotide Polymorphisms in CD40L Predict Endothelial Complications and Mortality After Allogeneic Stem-Cell Transplantation.

Rachakonda SP, Dai H, Penack O, Blau O, Blau IW, Radujkovic A, Müller-Tidow C, Kumar R, Dreger P, Luft T.

J Clin Oncol. 2018 Mar 10;36(8):789-800. doi: 10.1200/JCO.2017.76.4662. Epub 2018 Jan 25.

PMID:
29369699
5.

Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.

Berenstein R, Nogai A, Waechter M, Blau O, Kuehnel A, Schmidt-Hieber M, Kunitz A, Pezzutto A, Dörken B, Blau IW.

Mol Carcinog. 2016 Dec;55(12):1927-1939. doi: 10.1002/mc.22440. Epub 2015 Nov 24.

PMID:
27023728
6.

Tyrosine Kinases in Cancer.

Blau O, Afanasyev B, Blau IW.

Biomark Insights. 2015 Nov 2;10(Suppl 3):41-2. doi: 10.4137/BMI.S34403. eCollection 2015. No abstract available.

7.

Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.

Garg M, Nagata Y, Kanojia D, Mayakonda A, Yoshida K, Haridas Keloth S, Zang ZJ, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ding LW, Alpermann T, Sun QY, Lin DC, Chien W, Madan V, Liu LZ, Tan KT, Sampath A, Venkatesan S, Inokuchi K, Wakita S, Yamaguchi H, Chng WJ, Kham SK, Yeoh AE, Sanada M, Schiller J, Kreuzer KA, Kornblau SM, Kantarjian HM, Haferlach T, Lill M, Kuo MC, Shih LY, Blau IW, Blau O, Yang H, Ogawa S, Koeffler HP.

Blood. 2015 Nov 26;126(22):2491-501. doi: 10.1182/blood-2015-05-646240. Epub 2015 Oct 5.

8.

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia.

Berenstein R, Blau IW, Suckert N, Baldus C, Pezzutto A, Dörken B, Blau O.

J Exp Clin Cancer Res. 2015 May 22;34:55. doi: 10.1186/s13046-015-0173-2.

9.

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.

Berenstein R, Blau O, Nogai A, Waechter M, Slonova E, Schmidt-Hieber M, Kunitz A, Pezzutto A, Doerken B, Blau IW.

BMC Cancer. 2015 Feb 18;15:68. doi: 10.1186/s12885-015-1078-3.

10.

Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy.

Blau O, Blau IW.

Stem Cells Cloning. 2014 Dec 4;7:101-8. doi: 10.2147/SCCAA.S50514. eCollection 2014. Review.

11.

Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease.

Rachakonda SP, Penack O, Dietrich S, Blau O, Blau IW, Radujkovic A, Isermann B, Ho AD, Uharek L, Dreger P, Kumar R, Luft T.

J Clin Oncol. 2014 Oct 20;32(30):3421-7. doi: 10.1200/JCO.2013.54.4056. Epub 2014 Sep 15.

PMID:
25225421
12.

Association between low uric acid levels and acute graft-versus-host disease.

Ostendorf BN, Blau O, Uharek L, Blau IW, Penack O.

Ann Hematol. 2015 Jan;94(1):139-44. doi: 10.1007/s00277-014-2180-3. Epub 2014 Aug 31.

PMID:
25172456
13.

Comparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemia.

Berenstein R, Blau IW, Kar A, Cay R, Sindram A, Seide C, Blau O.

J Exp Clin Cancer Res. 2014 May 21;33:44. doi: 10.1186/1756-9966-33-44.

14.

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.

Mensen A, Jöhrens K, Anagnostopoulos I, Demski S, Oey M, Stroux A, Hemmati P, Westermann J, Blau O, Wittenbecher F, Movassaghi K, Szyska M, Thomas S, Dörken B, Scheibenbogen C, Arnold R, Na IK.

Blood. 2014 Aug 7;124(6):963-72. doi: 10.1182/blood-2013-11-539031. Epub 2014 May 15.

PMID:
24833353
15.

Bone marrow stromal cells in the pathogenesis of acute myeloid leukemia.

Blau O.

Front Biosci (Landmark Ed). 2014 Jan 1;19:171-80. Review.

PMID:
24389180
16.

JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia.

Kaeda J, Bonamino M, Ayres-Silva J, Solza C, Ringel F, Blau O, Daumas A, Oberender C, Dörken B, le Coutre P, Zalcberg I.

Leuk Lymphoma. 2014 Jan;55(1):128-35. doi: 10.3109/10428194.2013.797085. Epub 2013 Jun 5.

PMID:
23607255
17.

FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.

Neumann M, Coskun E, Fransecky L, Mochmann LH, Bartram I, Sartangi NF, Heesch S, Gökbuget N, Schwartz S, Brandts C, Schlee C, Haas R, Dührsen U, Griesshammer M, Döhner H, Ehninger G, Burmeister T, Blau O, Thiel E, Hoelzer D, Hofmann WK, Baldus CD.

PLoS One. 2013;8(1):e53190. doi: 10.1371/journal.pone.0053190. Epub 2013 Jan 24.

18.

Rabbit antithymocyte globulin (thymoglobulin) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.

Na IK, Wittenbecher F, Dziubianau M, Herholz A, Mensen A, Kunkel D, Blau O, Blau I, Thiel E, Uharek L, Scheibenbogen C, Rieger K, Thiel A.

Haematologica. 2013 Jan;98(1):23-30. doi: 10.3324/haematol.2012.067611. Epub 2012 Jul 16.

19.

Molecular analysis of different FLT3-ITD mutations in acute myeloid leukemia.

Blau O, Berenstein R, Sindram A, Blau IW.

Leuk Lymphoma. 2013 Jan;54(1):145-52. doi: 10.3109/10428194.2012.704999. Epub 2012 Sep 5.

PMID:
22721497
20.

Molecular investigation of Ewing sarcoma: about detecting translocations.

Blau O.

EMBO Mol Med. 2012 Jun;4(6):449-50. doi: 10.1002/emmm.201200226. Epub 2012 Mar 29. No abstract available.

21.

Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts.

Blau O, Baldus CD, Hofmann WK, Thiel G, Nolte F, Burmeister T, Türkmen S, Benlasfer O, Schümann E, Sindram A, Molkentin M, Mundlos S, Keilholz U, Thiel E, Blau IW.

Blood. 2011 Nov 17;118(20):5583-92. doi: 10.1182/blood-2011-03-343467. Epub 2011 Sep 23.

22.

Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation.

Neumann M, Blau IW, Burmeister T, Tietze-Buerger C, Blau O, Gerbitz A, Uharek L, Thiel E.

Ann Hematol. 2011 Aug;90(8):911-6. doi: 10.1007/s00277-011-1171-x. Epub 2011 Feb 12.

PMID:
21318573
23.

Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.

Heesch S, Goekbuget N, Stroux A, Tanchez JO, Schlee C, Burmeister T, Schwartz S, Blau O, Keilholz U, Busse A, Hoelzer D, Thiel E, Hofmann WK, Baldus CD.

Haematologica. 2010 Jun;95(6):942-9. doi: 10.3324/haematol.2009.016386. Epub 2010 Apr 30.

24.

Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.

Schmidt-Hieber M, Blau IW, Richter G, Türkmen S, Bommer C, Thiel G, Neitzel H, Stroux A, Uharek L, Thiel E, Blau O.

Cancer Genet Cytogenet. 2010 Apr 15;198(2):135-43. doi: 10.1016/j.cancergencyto.2010.01.005. Erratum in: Cancer Genet Cytogenet. 2010 Jul 1;200(1):73.

PMID:
20362228
25.

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E.

N Engl J Med. 2009 Feb 12;360(7):692-8. doi: 10.1056/NEJMoa0802905.

26.
27.

Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.

Blau IW, Schmidt-Hieber M, Leschinger N, Göldner H, Knauf W, Hopfenmüller W, Thiel E, Blau O.

Ann Hematol. 2007 Aug;86(8):583-9. Epub 2007 Apr 28.

PMID:
17468869
28.

Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.

Blau O, Hofmann WK, Baldus CD, Thiel G, Serbent V, Schümann E, Thiel E, Blau IW.

Exp Hematol. 2007 Feb;35(2):221-9.

PMID:
17258071
29.

"Size-selectivity" in the template-directed assembly of dinuclear triple-stranded helicates.

Albrecht M, Blau O, Frohlich R.

Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):4867-72.

30.

Molecular analysis of childhood acute lymphoblastic leukemia in Israel.

Blau O, Avigad S, Frisch A, Kilim Y, Stark B, Kodman Y, Luria D, Cohen IJ, Zaizov R.

Leuk Res. 1998 Jun;22(6):495-500.

PMID:
9678715
31.

Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.

Blau O, Avigad S, Stark B, Kodman Y, Luria D, Cohen IJ, Zaizov R.

Leuk Res. 1997 Aug;21(8):721-9.

PMID:
9379679
32.

A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.

Avigad S, Barel D, Blau O, Malka A, Zoldan M, Mor C, Fogel M, Cohen IJ, Stark B, Goshen Y, Stein J, Zaizov R.

Oncogene. 1997 Apr 3;14(13):1541-5.

33.

Ala244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews.

Tamary H, Fromovich Y, Shalmon L, Reich Z, Dym O, Lanir N, Brenner B, Paz M, Luder AS, Blau O, Korostishevsky M, Zaizov R, Seligsohn U.

Thromb Haemost. 1996 Sep;76(3):283-91.

PMID:
8883260
34.

A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)--case report and review of the literature.

Stark B, Resnitzky P, Jeison M, Luria D, Blau O, Avigad S, Shaft D, Kodman Y, Gobuzov R, Ash S, et al.

Leuk Res. 1995 Jun;19(6):367-79. Review.

PMID:
7596149
35.

The autosomal dominant polycystic kidney disease gene in a Jewish family from Uzbekistan is PKD1.

Frisch A, Frydman M, Blau O, Narinsky R, Morduchowicz G, Boner G, Bachner L, Steinherz R.

Isr J Med Sci. 1992 Oct;28(10):700-5.

PMID:
1356950
36.

A cell line with unusual characteristics from an ovarian carcinoma patient: modulation of sensitivity to antitumour drugs.

Wasserman L, Aviram R, Levavi H, Ovadia J, Shneyuor Y, Frisch A, Blau O, Beery E, Novogrodsky A, Nordenberg J.

Eur J Cancer. 1992;28(1):22-7.

PMID:
1348952

Supplemental Content

Support Center